Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/oncogenex-reports-third-quarter-2009-financial-results-14740-7/;/a><br) was not found.

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 7 ; a><br at Google

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 7 ; a><br at Yahoo

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 7 ; a><br at Msn

Google
 
(Date:11/23/2009)...RONTO, November 23, 2009 - The time of day matters...o a new paper produced by a research team led by P...carborough,s vice-principal for research and colle...y at the St. George campus. , Capitalizing on ...plar tree, the research team examined how poplar t...
(Date:11/23/2009)...AMPAIGN, Ill. A new study provides "incontroverti...Toba on the island of Sumatra about 73,000 years a...les from the epicenter, researchers report. , Th...s of ash into the atmosphere, leaving a crater (no...ilometers long and 35 kilometers wide. Ash from th...
(Date:11/23/2009)...BIRMINGHAM, Ala. A new study by University of Ala...dy-mass index (BMI) and co-existing medical condit...urvival observed among African-Americans compared ...y is published online Nov. 23 in Cancer , a journ... indicates that although BMI and co-morbidity are ...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 1AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 2
(Date:11/25/2009)...wire-USNewswire/--AnarticlebyJanetWoodcock,M.D.,di...,titled"ADifficultBalance-PainManagement,DrugSafet...nglandJournalofMedicine. ,, (Logo: http://www.n...nthearticle,WoodcockdiscussesFDAeffortstostrikeaba...tandmanagingtherisksposedbyvariousanalgesics.Asexa...
(Date:11/25/2009)... statistically significant survival benefit from a...ceptor (ER)-positive tumors had high levels of pho...S118-P), according to a brief communication publis...onal Cancer Institute . , Approximately 50% of b...inical studies have shown that ER-alpha S118-P is ...
(Date:11/25/2009)...nd treatment clinics to resume Monday, Nov. 30 , ... 25, 2009 -- Centegra Health System is continuing ...s at four Centegra Primary Care (CPC) vaccination ...ved. The clinics are at CPC sites in Huntley, Wood...s follows: ,   From 4:30 to 7:30 p.m. ...
(Date:11/25/2009)...e-USNewswire/--TheAmericanAssociationforHomecareen...28,whichisdesignedtosubstantiallyimprovetoolsandre...sintroducedbySen.GeorgeLeMieux(R-Fla.). ,, TheL...ciationforHomecareoutlinedinits13-pointanti-frauda...ebruary.Thoseprovisionsincludecallingforreal-timea...
(Date:11/25/2009)...ill tumor cells, study finds , , WEDNESD...elivered in a fingernail-size implant eliminated m...The method uses polymer disks, 8.5 millimeters in ...gens and implanted under the skin to reprogram the...rsity scientists who developed the implant predict...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
GeneSnap from SYNGENE
DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
Mouse Anti-XAGE2 Polyclonal Antibody, Unconjugated from Abnova Corporation
...recombinant or native proteins are used to immuniz...n protocol optimized in time, quantity of antigen ...nd the use of 2 animals per protocol in order to a...n a 77-day protocol is approximately 75 mL per rab...
Biology Products:
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products:
(Date:11/24/2009)...KJAVIK,Iceland,November24/PRNewswire-FirstCall/--d...eapprovalofallofits,"firstday"motionsbytheU.S.Bank...yCourt").deCODElastweekfiledavoluntarypetitionfor,...ewiththe,BankruptcyCourt. , Theordersissuedby...ateitsbusinessduringtheChapter11proceedings.Inpart...
(Date:11/24/2009)...MATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neuroge...cusedondevelopingandcommercializingnovelpainmanage...sidentandChiefExecutiveOfficer,isscheduledtopresen...obeheldDecember1-2,2009atTheNewYorkPalaceHotelinNe...,ChiefFinancialOfficer,willbeavailabletorespondtoq...
(Date:11/24/2009)...TTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.anno...entAuthority(OPDA)wererecentlyawarded$2millionbyWa...d(CERB)inaprivate/publicpartnershiptoconstructthes...nCounty,WA. ,, "Thisinvestmentwillsignificantly...reenjobstoLincolnCounty,"saidBlueMarbleEnergyCEOKe...
(Date:11/24/2009)...maryefficacyendpointhasbeenmetforpatientswithadvan...BECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZentar...lbiopharmaceuticalcompanyfocusedonendocrinetherapy...aPhase2studywithitstargetedcytotoxicpeptideconjuga...orrecurrentendometrialcancer.Inapersonalizedhealth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nas...int-of-carebloodanalysissystems,announcedtodaythat...lpresentatthe21stAnnualPiperJaffrayHealthCareConfe...ferencewillbeheldattheNewYorkPalaceHotelinNewYorkC...facturesandmarketsportablebloodanalysissystemsforu...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq: N...uctsforminimallydisruptivesurgicaltreatmentsforthe...nMonday,November30,2009,at5:30p.m.ET/2:30p.m.PT.Th...eimbursementfortheCompany,sproductsandwillincludec...swersession.Thedial-innumbersare1-877-407-4018ford...
(Date:11/25/2009)...25/PRNewswire/--Reportlinker.comannouncesthatanewm..., IntranasalDrugDelivery-USMarketTrends&Analy...al-Drug-Delivery---US-Market-Trends--Analysis.html...inganexpansionoftherapeuticapplicationsfromthedeli...ryofsystemictherapeuticdrugs.Thefutureofthetechnol...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 1Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 3Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 4Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3Household Insecticides May Be Linked to Autoimmune Diseases 59735 1Household Insecticides May Be Linked to Autoimmune Diseases 59735 2Household Insecticides May Be Linked to Autoimmune Diseases 59735 3